Skip to main content
Varinder Kaur, MD, Oncology, Charlottesville, VA

VarinderKaurMDFACP

Oncology Charlottesville, VA

Hematologic Oncology

Associate Professor

Dr. Kaur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kaur's full profile

Already have an account?

  • Office

    1240 Lee St
    Charlottesville, VA 22908
    Phone+1 434-924-9333

Education & Training

  • University of Arkansas for Medical Sciences
    University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 2012 - 2015
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2009 - 2012
  • Government Medical College Chandigrah
    Government Medical College ChandigrahClass of 2004

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2016 - 2026
  • AR State Medical License
    AR State Medical License 2014 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Excellence in Clinical Care University of Virginia, Department of Medicine, 2019
  • Fellow, American College of Physicians American College of Physicians, 2019

Clinical Trials

Publications & Presentations

Journal Articles

  • Addressing Opioid-Associated Constipation Using Quality Oncology Practice Initiative Scores and Plan-Do-Study-Act Cycles  
    Varinder Kaur, MD, Sajjad Haider, MD, Appalanaidu Sasapu, MD, Paulette Mehta, MD, Konstantinos Arnaoutakis, MD, Issam Makhoul, MD, Journal of Oncology Practice, 10/31/2016
  • PTHrP(12-48) localization is intracellular and it inhibits cell proliferation and osteoclastogenesis  
    Kaur V, Kamalakar A,Akel N, Leitzel K, Allan L, Suva LJ, Cancer Research 75(15 Supplement):1041-1041, 8/1/2015

Abstracts/Posters

  • 1161 Immunotherapy (IO) associated cardiotoxicity and out-comes with re-challenge
    Nakul Dar, Omar Elghawy, Varinder Kaur, Journal for ImmunoTherapy of Cancer, SITC 39th Annual Conference 2024 (Nov 8-10), Houston, USA, 11/1/2024
  • 1468 Evaluation of safety and immunogenicity of a melanoma vaccine, with or without a systemic agonistic CD27 antibody (CDX-1127), in patients with stage II-IV melanoma
    Feifan Xu, Gina R Petroni, Andrew S Poklepovic, Elizabeth Gaughan, Kimberly A Chianese-Bullock, Kelly T Smith, Paul Wright, Jennifer Bryant, Craig L Slingluff, Timothy..., Journal for ImmunoTherapy of Cancer, SITC 39th Annual Conference 2024 (Nov 8-10), Houston, USA, 11/1/2024
  • 1466 Phase I/II clinical trial of a melanoma vaccine targeting shared nonmutated antigens and a shared mutated neoantigen with an agonistic CD40 antibody (CDX-1140) pl...
    Emily K Ninmer, Gina R Petroni, Brian Gastman, Elizabeth Gaughan, James M Isaacs, Kathleen Haden, Varinder Kaur, Kimberly A Chianese-Bullock, Kelly T Smith, Paul Wrigh..., Journal for ImmunoTherapy of Cancer, SITC 39th Annual Conference 2024 (Nov 8-10), Houston, USA, 11/1/2024
  • Join now to see all

Authored Content

  • PARP Inhibitors As Single Agents or Combination Therapy in Melanoma: Where Do We Stand?July 2022
  • Combination Immunotherapy and BRAF/MEK Inhibitor Therapy for BRAFV600-Mutated Advanced Melanoma: Are We There Yet?April 2021

Press Mentions

  • Immunotherapy for the Treatment of Head and Neck Cancers
    Immunotherapy for the Treatment of Head and Neck CancersApril 27th, 2021
  • CME Information - May 2018
    CME Information - May 2018January 28th, 2018
  • High Blood Sugar Elevates Breast Cancer Risks
    High Blood Sugar Elevates Breast Cancer RisksJune 9th, 2015
  • Join now to see all

Committees

  • Member, American Board of Internal Medicine Medical Oncology Item Writing Task Force 2023 - Present
  • Member, American Society of Clinical Oncology Self Evaluation Program (ASCO-SEP) Medical Oncology Self-Evaluation Program 2023 - Present
  • Member, ACP Virginia Chapter Governor's Advisory Council 2022 - Present
  • Member, American Society of Clinical Oncology Educational Book Expert Panel 2020 - Present
  • Member, ASCO Systemic Therapy for Melanom Guidelines Panel 2018 - Present
  • Member, ORIEN Scientific Review Committee 2017 - Present
  • Member, ASCO/ABIM Test Material Development Subcommittee 2019 - 2021

Professional Memberships

Other Languages

  • Punjabi, Hindi